SCHEMBL31283429

SCHEMBL31283429

CC(C)(C)OC(=O)N1CCN(C2(C)CN(c3cc(Cl)nc(C(F)(F)F)n3)C2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.40
▸ GPR119 Q8TDV5 6/20 0.40
▸ HDAC4 P56524 1/20 0.38
▸ CKS1B P61024 2/20 0.38
▸ SKP1 P63208 2/20 0.38
▸ SKP2 Q13309 2/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ SUV39H2 Q9H5I1 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ HTT P42858 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30867784 0.82 GPR119 (0.41) POLBGPR119HDAC4CKS1BSKP1
SCHEMBL1580434 0.77 GPR119 (0.48) POLBGPR119HDAC4CKS1BSKP1
SCHEMBL29668815 0.77 GPR119 (0.48) POLBGPR119HDAC4CKS1BSKP1
SCHEMBL30867722 0.76 KHK (0.38) POLBGPR119HDAC4CKS1BSKP1
SCHEMBL38654229 0.76 KHK (0.38) POLBGPR119HDAC4CKS1BSKP1
SCHEMBL3991539 0.75 CKS1B (0.50) POLBGPR119CKS1BSKP1SKP2
SCHEMBL24851452 0.74 CKS1B (0.49) POLBGPR119CKS1BSKP1SKP2
SCHEMBL1280129 0.74 GPR119 (0.56) POLBGPR119CKS1BSKP1SKP2
SCHEMBL30162245 0.74 CKS1B (0.49) POLBGPR119CKS1BSKP1SKP2
SCHEMBL15390642 0.74 ALDH1A1 (0.50) GPR119HDAC4MAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705293-A1 SPIRO-HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2026-03-11 — — EP disclosed
WO-2024229317-A1 SPIRO-HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-11-07 — — WO disclosed
Send feedback